☰

Greggory S. LaBerge, Ph.D. - Publications

Affiliations: 
2011 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Genetics, Immunology, Bioinformatics Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Laberge GS, Duvall E, Haedicke K, Pawelek J. Leukocyte⁻Cancer Cell Fusion-Genesis of a Deadly Journey. Cells. 8. PMID 30781683 DOI: 10.3390/Cells8020170  0.347
2017 LaBerge GS, Duvall E, Grasmick Z, Haedicke K, Pawelek J. A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis. Plos One. 12: e0168581. PMID 28146572 DOI: 10.1371/Journal.Pone.0168581  0.313
2013 Lazova R, Laberge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT, Pawelek JM. A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer. Plos One. 8: e66731. PMID 23840523 DOI: 10.1371/Journal.Pone.0066731  0.495
2013 Lazova R, LaBerge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT, Pawelek JM. A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer Plos One. 8. DOI: 10.1371/journal.pone.0066731  0.433
2011 Lazova R, Laberge GS, Duvall E, Spoelstra N, Sznol M, Cooper D, Spritz R, Pawelek JM. Abstract 1477: Tumor cell-leukocyte fusion in human cancer: A melanoma brain metastasis with a donor-patient hybrid genome following allogeneic BMT Cancer Research. 71: 1477-1477. DOI: 10.1158/1538-7445.Am2011-1477  0.521
2009 Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: Two genetic association studies and a meta-analysis of published data Pigment Cell and Melanoma Research. 22: 230-234. PMID 19175525 DOI: 10.1111/J.1755-148X.2009.00543.X  0.561
2008 Laberge GS, Birlea SA, Fain PR, Spritz RA. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population Pigment Cell and Melanoma Research. 21: 206-208. PMID 18426414 DOI: 10.1111/J.1755-148X.2008.00443.X  0.569
2008 LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not Journal of Investigative Dermatology. 128: 1757-1762. PMID 18200060 DOI: 10.1038/Sj.Jid.5701233  0.592
2007 Jin Y, Mailloux CM, Gowan K, Riccardi SL, Laberge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease New England Journal of Medicine. 356: 1216-1225. PMID 17377159 DOI: 10.1056/Nejmoa061592  0.641
2005 Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo Pigment Cell Research. 18: 300-305. PMID 16029422 DOI: 10.1111/J.1600-0749.2005.00242.X  0.645
2003 Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA. A genomewide screen for generalized vitiligo: Confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci American Journal of Human Genetics. 72: 1560-1564. PMID 12707860 DOI: 10.1086/375451  0.696
Show low-probability matches.